Oneness Biotech receives a Korean patent on the producing recombinant glycoproteins with modified glycosylation.
· Issued by Oneness Biotech Co., Ltd.
Close
Today's Information
Provided by: ONENESS BIOTECH CO., LTD.
SEQ_NO
1
Date of announcement
2022/02/15
Time of announcement
18:03:08
Subject
Oneness Biotech Co., Ltd. receives a Korean patent
on the producing recombinant glycoproteins with modified
glycosylation.
Date of events
2022/02/15
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/02/15
2.Company name:ONENESS BIOTECH CO., LTD.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:
The Company has been informed by the patent agency that the methods for
glycan modification on recombinant protein , has been granted a Korean
patent entitled " METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH
MODIFIED GLYCOSYLATION" under the patent number 10-2333923.
6.Countermeasures:None
7.Any other matters that need to be specified:None
